Product Information

CETIRIZINE HCL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0517 per EA under NDC 00378363501. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 27, 2007.

CETIRIZINE HCL 5 MG TABLET

cetirizine hydrochloride
$0.0517per EA
OTC

Strength

5 mg/1

NDC

00378363501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CETIRIZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076677

FDA Approved

12/27/2007

On Market Since

12/27/2007

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for CETIRIZINE HCL 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0517 per EA
All-time high$0.0858 (Nov 13, 2019)
All-time low$0.0382 (Nov 20, 2024)
52-week high$0.0526
52-week low$0.0472
Median price$0.0557
Average price$0.0567
Largest weekly change+48.6% (May 22, 2019)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-1.7%

1M

-1.7%

3M

+7.9%

6M

+3.8%

1Y

+8.6%

3Y

-1.0%

5Y

-2.7%

All

-21.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cetirizine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CETIRIZINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0517 per EA (NDC 00378363501), effective Aug 19, 2026.

How has the price of CETIRIZINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG TABLET has declined 21.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG TABLET has ranged from a low of $0.0382 (Nov 20, 2024) to a high of $0.0858 (Nov 13, 2019), with a median of $0.0557 per EA.

Are there cheaper alternatives to CETIRIZINE HCL 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CETIRIZINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CETIRIZINE HCL 5 MG TABLET?

CETIRIZINE HCL 5 MG TABLET (NDC 00378363501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.